Encompass COO disposes 506 shares for tax withholding

Encompass Health Corp executive Patrick William Tuer, EVP and Chief Operating Officer, reported a tax-related share disposition.

Accepted by SEC EDGAR 02/25/2026 - 09:29 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Encompass Health Corp executive Patrick William Tuer, EVP and Chief Operating Officer, reported a tax-related share disposition. On the reported date, 506 shares of Encompass Health common stock were withheld or surrendered at $106.15 per share to cover tax withholding obligations from vesting restricted stock. After this tax-withholding disposition, Tuer directly owned 25,982 shares of Encompass Health common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 506 shares

Exercise Price or Tax Liability 1 txn

Insider Tuer Patrick William

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	506	$106.15	$54K

Holdings After Transaction: Encompass Health Common Stock — 25,982 shares (Direct)

Holdings Before and After: Encompass Health Common Stock, 26,488 to 25,982 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) COO Patrick Tuer report on this Form 4?

Patrick William Tuer reported a tax-withholding disposition of 506 Encompass Health common shares. The shares were withheld or surrendered to satisfy tax obligations triggered by the vesting of related restricted stock, rather than an open-market sale, and were priced at $106.15 per share.

How many Encompass Health (EHC) shares were disposed of for taxes and at what price?

The filing shows 506 Encompass Health common shares disposed of for tax withholding purposes. These shares were valued at $106.15 per share, reflecting shares withheld or surrendered to cover tax liabilities from vesting restricted stock, not a discretionary market transaction or traditional sale.

How many Encompass Health (EHC) shares does Patrick Tuer own after this transaction?

After the tax-withholding disposition, Patrick William Tuer directly owns 25,982 Encompass Health common shares. This post-transaction balance reflects his remaining direct holdings following the surrender of 506 shares to satisfy tax obligations associated with the vesting of restricted stock awards.

Was the Encompass Health (EHC) Form 4 transaction an open-market sale?

No, the Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were withheld or surrendered to pay insider tax withholding obligations when restricted stock vested, consistent with transaction code “F” for payment of tax liability using company securities.

What does transaction code "F" mean in the Encompass Health (EHC) Form 4?

Transaction code “F” indicates payment of an exercise price or tax liability by delivering securities. In this case, 506 Encompass Health shares were withheld or surrendered specifically to satisfy tax withholding obligations from vesting restricted stock, rather than being sold in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		506(1)	D	$106.15	25,982	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.